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Abstract
Background: Herpes simplex virus (HSV) is one of the most frequent viruses affecting females’ sexual and reproductive health.
Objectives: The current study aimed to determine the HSV serostatus and viral shedding in patients with ongoing miscarriage.
Methods: Two hundred and eight females were included in the study; IgM antibodies against HSV1/2 were detected in serum sam-
ples; the real-time polymerase chain reaction (PCR) quantification of viral DNA was performed on cervicovaginal samples. Positive
females were tested for IgG anti-HSV-2.
Results: The results indicated 12.5% IgM-positive and 2.9% real-time PCR positive samples. None of the patients was positive for
the both analyses, simultaneously. Among IgM-positives cases, 16.6% were also IgG-positive; whilst in PCR-positives samples, 20%
were also IgG-positive. The presence of viral DNA without detectable IgM or IgG antibodies could indicate a recent infection or a
reactivation with low copy numbers.
Conclusions: IgM alone is not a marker for viral shedding in genital tract. Molecular testing in conjunction of IgG test should be
evaluated as an option to determine HSV status, and applied for research on HSV genital infections records.
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1. Background
Spontaneous abortion defined as the termination of a
pregnancy prior to completion of 20 weeks of gestation, is
one of the most frequent adverse pregnancy outcomes, es-
timated in 12% - 76% of all pregnancies (1-3). The most fre-
quent causes of pregnancy loss in the first trimester are of
genetic origin (4). Other important risk factors are mater-
nal age, placental inflammation and infection (5, 6); how-
ever, the etiology is often uncertain.
It is believed that some of the infectious agents in-
volving in pregnancy loss and congenital malformations
are included in the TORCH screening: Toxoplasma gondii,
cytomegalovirus (CMV), rubella and herpes simplex virus
(HSV) amongst others. HSV is one of the most frequent
sexually transmitted viruses, and the cause of significant
morbidity in the affected populations; recent estimates
indicate a large burden of genital herpes worldwide (7).
Asymptomatic shedding is important in HSV transmission
dynamics. The most devastating consequence is neonatal
herpes; 90% of neonatal infections are transmitted intra-
partum; neonates born from mothers recently infected or
without detectable antibodies at the time of delivery are
at higher risk of disease and death (8, 9). As mentioned,
HSV is traditionally considered amongst the risk factors for
spontaneous and recurrent abortion, and the serological
tests show utility in some settings; however it is suggested
to discontinue the routine use in others (10). As recently
reviewed by Giakoumelou et al. (11), HSV role in sponta-
neous abortion is still controversial and further studies are
required. Studies by el-Sayed Zaki and Goda (12) reported
40% IgM positivity in females with pregnancy loss; while
Sebastian et al. (13) showed statistically significant rela-
tionship between pregnancy loss and anti-HSV IgM posi-
tivity (P = 0.022). Additional methods employed to diag-
nose HSV infection include nucleic acid amplification tech-
niques; although they are powerful tools, the molecular
detection should not always correspond to the presence of
symptoms or lesions, or to the serological diagnosis (14, 15).
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2. Objectives
Therefore, the clinical significance of the tests can vary.
The current study aimed to gain knowledge on the fre-
quency of HSV shedding in patients with ongoing sponta-
neous miscarriage and to discuss the results that can be ob-
tained when screening the same females with serological
and viral DNA tests.
3. Methods
The current cross-sectional descriptive study included
patients with up to 20 weeks of gestation, attending hospi-
tal regional Ignacio Garcia Tellez in Merida, Yucatan, pre-
senting gestational vaginal bleeding; further defined as
acute miscarriage and missed or incomplete miscarriage
diagnosed by ultrasound examinations. All participants
signed an informed consent. The project was approved by
the corresponding bioethical committee (reference num-
ber: CEI-CIR-14-09). On the same examination, cervicovagi-
nal samples were collected by cytobrush and deposited in 5
mL of phosphate-buffered saline (PBS) with penicillin 500
U/mL, streptomycin 500 mg/mL and gentamicin 4 mg/mL.
Immediately, blood-serum samples were obtained from
venous punctuation (approximately 5 mL). Samples were
kept at 4°C during transportation to the virology labora-
tory of the regional research center for processing.
Automated DNA extraction of cervicovaginal samples
was performed using MagNa Pure LC total nucleic acid iso-
lation kit (Roche). Extracted DNAs were tested for HSV
using real-time polymerase chain reaction (PCR) amplifi-
cation of the UL30 gene which is common for both HSV
types 1 and 2; according to the previously described pro-
tocol (16), using FAM/TAMRA-labelled TaqMan probe, the
amplification was performed on a 7500-Fast Thermocyler
(Applied Biosystems). For quantitative determinations,
standard curves were performed using serial log10 dilu-
tions of cloning vectors containing the corresponding HSV
genome fragment from HSV types 1 and 2 reference strains
(McIntyre and G respectively, kindly donated by BL Barron
Romero). As an internal control for real-time PCR,β-globin
gene was amplified from human genome (16) and the re-
sults of viral quantification were corrected to be expressed
in a total volume of one millilitre of reaction buffer.
Serum samples were analysed by an enzyme im-
munoassay (EIA) to detect IgM antibodies against HSV1/2
(DRG, Germany) following the manufacturer’s instruc-
tions. IgG EIA test against HSV-2 (DRG, Germany) was fur-
ther performed to all positives to any of the previous tests.
Each assay included the appropriate positive and nega-
tive controls. The clinical records were transferred to a
database in SPSS software ver. 21.
4. Results
The mean age of the 208 females in the study was 28.37
years, ranging from 14 to 43. The majority of the sub-
jects (n = 185, 88.9%) were in their first trimester of ges-
tation and 22 (10.6%) subjects in the second trimester (up
to week 20 were included exclusively); one patient had
missing data. The described miscarriage categories were:
145 subjects with acute miscarriage (includes complete
miscarriage); 30 subjects with incomplete miscarriage (as
confirmed by ultrasound examination); 25 subjects with
missed miscarriage (as confirmed by ultrasound); 8 sub-
jects with other/not defined.
None of them presented ulcers or lesions compatible
to genital HSV at the time of sampling; none referred gen-
ital HSV episodes in the past. It was considered a low-risk
population as the majority were monogamous (78.4% were
married, 98.6% had only one sexual partner for the last
six months), had never presented sexually transmitted dis-
eases (STDs) (92.8%), had high school diploma or higher
(87%) and the mean age of sexual onset was 20.1 years (13
- 39 years). In IgM serological analysis, 12.5% (26/208) were
positive; while 2.9% (6/208) were positive in real-time PCR
analysis. None of the patients was positive for both PCR
and IgM analyses, simultaneously. The results are summa-
rized in Table 1 (only the positive samples in either test are
presented).
The ranges of viral loads in PCR-positives were esti-
mated from 800 to 178 and 350 copies/mL, with a mean of
32,933 copies/mL. Among the IgM positives, 16% were pos-
itive for HSV-2 IgG (4/25, one not tested). Among real-time
PCR positives, 20% were also positive for HSV-2 IgG (1/5, one
not tested).
5. Discussion
There were 12.5% IgM seropositives and 2.9% positives
for viral DNA detection in cervicovaginal samples. Previ-
ously, the utility of IgM serology test for HSV-2 was dis-
cussed; a study by Choudhry et al. (17) suggested a poor di-
agnostic value of this test in sexual transmitted infections
(STIs) clinics, while other studies by el-Sayed Zaki and Goda
(12) recommended the specific HVS-2 IgM screening to di-
agnose spontaneous and repetitive abortion cases. More-
over, results of another study recommended HSV1/2 IgM
combined test to estimate recent infection burden (18).
The current study used combined HSV1/2 IgM and real-time
PCR tests because of the changing epidemiology of HSV
types; HSV-1 was increasingly detected as the cause of geni-
tal herpes worldwide (19, 20). As indicated, a real-time PCR
positive sample did not correspond to IgM detection in the
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Table 1. Results of Serological and Real-Time PCR Testing to Determine HSV Infection in the Study Subjectsa , b
Sample Code IgMHSV1/2 IgGHSV-2 Real-time PCR for HSV1/2 Viral Load in Copies/mL Viral Load in Copies per 10,000 cells
287 + - - 0 0
290 + - - 0 0
291 + - - 0 0
292 + + - 0 0
304 + + - 0 0
322 + Grey zone - 0 0
332 + - - 0 0
336 + - - 0 0
337 + - - 0 0
338 + - - 0 0
345 + - - 0 0
352 + - - 0 0
374 + + - 0 0
392 + - - 0 0
395 + - - 0 0
397 + Grey zone - 0 0
401 + - - 0 0
416 + - - 0 0
442 + NA - 0 0
621 + - - 0 0
682 + - - 0 0
684 + - - 0 0
715 - - + 3400 75
721 + + - 0 0
724 + - - 0 0
768 - - + 7750 119
779 - + + 178350 2833
788 - - + 800 17
819 - - + 850 3
822 - NA + 6450 146
827 + - - 0 0
aCoding: +, positive; -, negative; grey zone as established by the test manufacturer; NA, not available.
bViral load per 10,000 cells is adjusted toβ-globin copies.
studied group. The presence of viral DNA without IgM de-
tection could indicate a reactivation that may occur with-
out IgM rises (8). An example of this situation was the sam-
ple no. 779 (Table 1), which was positive for HSV-2 IgG and
PCR, but negative for IgM.
On the contrary, an HSV1/2 IgM positive test with a neg-
ative PCR could indicate one of the following possibilities:
a, infection of the oral mucosa, overestimating the rates of
genital infection; b, genital infection without detectable vi-
ral shedding at the moment of sampling. About the last
scenario, it is said that shedding episodes are highly vari-
able, and the detection depends on the applied methods,
duration of the study and anatomical site of sampling (21).
However, since the current study was cross-sectional sur-
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vey, viral shedding was tested only once.
It is clear that patients with positive HSV-2 IgG are in-
fected with HSV-2; however, an IgM1/2 positive result could
reflect a reactivation of either types not necessarily HSV-2.
It was the case of samples no. 292, 304, 374, and 721 (Table
1). The grey-zone could indicate that seroconversion is in
progress and might represent recent infection, as was the
samples no. 322 and 397.
HSV-2 IgG negative with IgM HSV1/2 positive could indi-
cate: a, a recent infection with either types; b, a reactivation
of HSV-1.
Finally, the study found PCR positive samples with neg-
ative HSV1/2 IgM and negative HSV-2 IgG tests; it was the
case of samples no. 715, 768, 788 and 819 (Table 1; no. 822
was not available for IgG testing). Although asymptomatic
shedding represents an important part of HSV epidemi-
ology, the clinical relevance of the obtained results is not
known; presumably, they may represent very recent expo-
sures to the virus. It is reported a higher risk for neonates
born to viral-positive seronegative mothers (8). However,
the miscarriage event cannot be linked to the viral shed-
ding, or to the presence of antibodies.
It is noteworthy that viral shedding quantification in
all samples was relatively low (800 - 7750 copies/mL). It is
unknown which viral levels may result in transmission,
but Gardella et al. (14, 15) reported transmission from PCR
low-positives even of 500 - 1,000 copies of DNA.
EIA for detection of IgG remains the most commonly
used tests, however, this test alone is not a marker of baby
exposure to mother’s infection at labour or sexual partner
exposure. IgM testing or periodic screening for transmis-
sibility is suggested by some authors; despite its low diag-
nostic value (17, 18). According to the current study obser-
vations, IgM HSV1/2 serology was not useful to estimate the
risk of exposure to viral shedding in the patients.
HSV infection dynamics is difficult to study. IgM and
real-time PCR testing could aid to identify different stages
of infection, in conjunction to IgG test. The presence of
anti-HSV1/2 IgM antibodies in the studied group did not
correspond to actual viral shedding in the genital tract.
Since the etiology of HSV in spontaneous abortion is still
not fully defined, patients with a positive real-time PCR
result, high viral loads and negative serology are of clin-
ical interest and for further research. The available stud-
ies show contradictory results about the etiological role of
HSV in spontaneous abortion (13, 22-24); therefore, more re-
search is needed. A limitation of the current study was that
abortive tissues were not available to test the presence of
HSV DNA, and that it was not a case-control study. Another
limitation was that data on oral herpetic lesions were not
available.
The current observations might be extrapolated for the
third trimester pregnancies, in which a positive PCR re-
sult with negative serology would represent higher risk for
transmission to the product, or in other cases higher risk
for transmission to the sexual partner, or for the future de-
velopment of genital ulcers; in agreement to what was pre-
viously suggested (8, 15).
It is important to consider the interpretation of each
available test, either for research, diagnosis or epidemiol-
ogy purposes. Cost-effectiveness studies in low resources
settings are needed to determine if molecular tests will be
a choice to prevent complications such as neonatal her-
pes in high-risk populations and concealed serodiscordant
partner. Nevertheless, molecular techniques rather than
serology applications are useful to investigate the effect of
HSV shedding during gestation and delivery.
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